(Q48426266)

11 February 2018

title

Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats (English)

1 reference

11 February 2018

1 reference

Azza S Awad

1

1 reference

11 February 2018

publication date

31 July 2006

1 reference

11 February 2018

published in

Vascular Pharmacology

1 reference

11 February 2018

volume

45

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

141-147

1 reference

11 February 2018

Partial leptin restoration increases hypothalamic-pituitary-adrenal activity while diminishing weight loss and hyperphagia in streptozotocin diabetic rats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Protective role of endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Arterial pressure control at the onset of type I diabetes: the role of nitric oxide and the renin-angiotensin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Hyperglycaemia in patients with acute ischaemic stroke: how often do we screen for undiagnosed diabetes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Nitric oxide and vascular responses in Type I diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Diabetes and hypertension physiopathology and therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Ventricular relaxation of diabetic spontaneously hypertensive rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Angiotensin II inhibits endothelial cell motility through an AT1-dependent oxidant-sensitive decrement of nitric oxide availability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Candesartan Reduces Oxidative Stress and Inflammation in Patients with Essential Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Lipid peroxidation and antioxidant status in experimental diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Hyperglycemia and focal brain ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Reactive oxygen species as mediators of angiotensin II signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Nitric oxide availability in diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

The role of hyperglycemia in acute stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Effect of losartan on the blood–brain barrier permeability in diabetic hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Structural alterations of tight junctions are associated with loss of polarity in stroke-prone spontaneously hypertensive rat blood-brain barrier endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Studies on the permeability of the blood-brain barrier in experimental diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Losartan Reduces Phenylephrine Constrictor Response in Aortic Rings From Spontaneously Hypertensive Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Product of extracellular-superoxide dismutase catalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Drug treatment of hypertension complicating diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-superoxide dismutase transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Central nervous system complications of diabetes mellitus--a perspective from the blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Enhanced hypothalamic AMP-activated protein kinase activity contributes to hyperphagia in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Angiotensin II in central nervous system physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Effect of Eugenia Jambolana seed kernel on antioxidant defense system in streptozotocin-induced diabetes in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

High D-glucose induces alterations of endothelial cell structure in a cell-culture model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Oxygen radicals in cardiovascular-renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Study of interaction between nitric oxide and ACE activity in STZ-induced diabetic rats: role of insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Candesartan reduces superoxide production after global cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Influence of hyperglycaemia on infarct size and clinical outcome of acute ischemic stroke patients with intracranial arterial occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Determination of malonaldehyde precursor in tissues by thiobarbituric acid test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Effect of nitric oxide synthase inhibitor on a hyperglycemic rat model of reversible focal ischemia: detection of excitatory amino acids release and hydroxyl radical formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

Free radical production and angiotensin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

The role of oxidative stress in diabetic vascular and neural disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.04.004

10.1016/J.VPH.2006.04.004

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018